Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin‐angiotensin blockers

AIMS: To characterize the effect of dapagliflozin on albuminuria and estimated glomerular filtration rate (eGFR) and to determine whether effects on albuminuria were mediated through changes in glycated haemoblogin (HbA1c), systolic blood pressure (SBP), body weight or eGFR. METHODS: We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Heerspink, H. J. L., Johnsson, E., Gause‐Nilsson, I., Cain, V. A., Sjöström, C. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850750/
https://www.ncbi.nlm.nih.gov/pubmed/26936519
http://dx.doi.org/10.1111/dom.12654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850750/
https://www.ncbi.nlm.nih.gov/pubmed/26936519
http://dx.doi.org/10.1111/dom.12654

Ejemplares similares